https://www.selleckchem.com/pr....oducts/Azacitidine(V
001) and uric acid (p-value 0.001) material on encrusted stent significantly decreased compared with the non-intervention group. Results of this study revealed that taking of potassium citrate after ureteral stent insertion significantly decreases the formation of calcium oxalate and uric acid encrusted material on Double-J stent so it could be recommended for prevention of stent encrustation in patients that primary stone analysis are calcium oxalate and uric acid stone. Results of this study revealed that taking of po
Beğen
Yorum Yap
Paylaş
